CancerWorld shared a post on LinkedIn:
“For Dr. Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, science is never about prestige-it’s about impact. Patients don’t have the luxury of slow progress, and neither should research.
Her career has been defined by turning discovery into cures:
- National Cancer Institute (NCI) Institute – early research, learning how simple systems solve human problems
- Jefferson Health – building translational programs, connecting labs to clinics, mentoring teams
- American Cancer Society – leading organizational transformation with mission and strategy
- Parker Institute – accelerating bold immunotherapy innovation with a curative focus.
She credits her mentors, her teams, and her upbringing for shaping her philosophy: “We don’t balance our portfolio with incremental science. It’s all about ambitious science… because we can cure cancer. And people need it.”
Read the full CancerWorld cover story by Gevorg Tamamyan here.”
Other articles from CancerWorld on OncoDaily.